Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | HTR2C | P28335 | 6/20 | 0.35 |
| ▸ | HTR2A | P28223 | 3/20 | 0.35 |
| ▸ | HTR2B | P41595 | 2/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5769370 | 0.86 | CD44 (0.35) | KDM4EHTR2CHTR2AHTR2BCYP2C19 | |
| SCHEMBL513565 | 0.76 | KDM4E (0.57) | KDM4E | |
| SCHEMBL29661474 | 0.76 | KDM4E (0.57) | KDM4E | |
| SCHEMBL3563842 | 0.76 | KDM4E (0.63) | KDM4ECYP2C19 | |
| Ethylene SCHEMBL8636905 | 0.72 | KDM4E (0.59) | KDM4ECYP2C19 | |
| SCHEMBL14483361 | 0.71 | KDM4E (0.56) | KDM4EHTR2CHTR2AHTR2BCYP2C19 | |
| SCHEMBL4195565 | 0.69 | DYRK1A (0.35) | HTR2CHTR2AHTR2B | |
| SCHEMBL12481059 | 0.68 | KDR (0.45) | — | |
| SCHEMBL10271926 | 0.68 | KDR (0.35) | KDM4E | |
| Hydrochloric Acid SCHEMBL30170812 | 0.68 | DYRK1A (0.34) | HTR2CHTR2AHTR2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2024368-A2 | 6,7,8,9-TETRAHYDRO-5H-PYRIMIDO[4,5-D]AZEPIN-4-YL]-AMINE DERIVATIVES AS MODULATORS OF TRPV1 FOR THE TREATMENT OF PAIN | Janssen Pharmaceutica, N.V. (BE) | 2009-02-18 | — | — | EP | claimed |
| WO-2007109355-A2 | 6,7,8, 9 -TETRAHYDRO- 5H- PYRIMIDO [4, 5-D] AZEPIN-4-YL] -AMINE DERIVATIVES AS MODULATORS OF TRPVL FOR THE TREATMENT OF PAIN | JANSSEN PHARMACEUTICA N.V. (BE) | 2007-09-27 | — | — | WO | claimed |